NCT06242574

Brief Summary

The aim of this study is to describe, using a non-interventional survey, the relevant aspects of health in adults with ADRD for the patients themselves, their carers and healthcare professionals. Commonalities and differences between these three stakeholders and according to the severity of the dementia will also be studied.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 15, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

January 19, 2024

Last Update Submit

September 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Assessment of the meaningful aspects of health that patients, care partners and clinicians consider most important when considering improvement in the ADRD patient's condition and when considering prevention of decline in the ADRD patient's condition

    questionnaire specially developed for the study containing a set of MAH ranking exercises and free text response questions

    day 1

  • Assessment of the meaningful aspects of health that patients, care partners and clinicians consider most important when considering prevention of decline in the ADRD patient's condition

    questionnaire specially developed for the study containing a set of MAH ranking exercises and free text response questions

    day1

Study Arms (3)

Adults with Alzheimer's disease and related dementia

75 patients with ADRD

Other: Survey

Care partners of Adults with Alzheimer's disease and related dementia

75 care partners for adults with ADRD

Other: Survey

Clinicians who treat patients with Alzheimer's disease and related dementia

25 healthcare practitioners

Other: Survey

Interventions

SurveyOTHER

Each group will have to complete a questionnaire online, taking about 30 minutes.

Adults with Alzheimer's disease and related dementiaCare partners of Adults with Alzheimer's disease and related dementiaClinicians who treat patients with Alzheimer's disease and related dementia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with ADRD, their care givers and Health-care practitioners

Adults with Alzheimer's disease and related dementia: 1. ADRD inclusive of the following : * Mild dementia due to Alzheimer's disease inclusive of: * Mild Cognitive Impairment (MCI), * Prodromal Alzheimer's disease, * Subjective cognitive impairment, * Early onset dementia due to Alzheimer's disease, * Mild Alzheimer's Disease * Frontotemporal dementia (FTD) - Frontal variant * Frontotemporal dementia (FTD) - Primary progressive aphasia * Lewy Body dementia (LBD) * Vascular dementia 2. Ability to read, understand and express non opposition 3. Aged 50 years or older 4. Patient affiliated to the social security system Care partners: 1. Unpaid care partners for adults with Alzheimer's disease and related dementia ■ A care partner is the primary person who cares for an adult with ADRD, including but not limited to partner, spouse, family member, or significant other of the individual with ADRD. Care partners will be recruited where they care for patients with: * Mild dementia due to Alzheimer's disease (inclusive of Mild Cognitive Impairment (MCI), Prodromal Alzheimer's disease, Subjective cognitive impairment, Early onset dementia due to Alzheimer's disease, Mild Alzhiemer's Disease ) * Moderate to severe dementia due to Alzheimer's disease * Frontotemporal dementia (FTD) - Frontal variant * Frontotemporal dementia (FTD) - Primary progressive aphasia * Lewy Body dementia (LBD) * Vascular dementia 2. Delivers at least 10 hours of additional care per week since diagnosis 3. Ability to read, understand and express non opposition 4. Aged 18 years or older 5. Subject affiliated to the social security system Health-care practitioners 1. Healthcare practitioners actively treating adults with ADRD, including: neurologists, geriatricians, psychiatrists, neuropsychologists and social workers 2. Currently treats a minimum of 10 ADRD patients 3. express non opposition

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

chu de Nice

Nice, 06100, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2024

First Posted

February 5, 2024

Study Start

April 15, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations